The mesenchymal stem cell therapy for canadians with multiple sclerosis (MESCAMS) clinical trial: Cell manufacturing of autologous bone marrow-derived mscs in ottawa

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) England), 2018-05, Vol.20 (5), p.S42-S42
Main Authors: Khan, S, Schafhauser, J, Davila, L, Saleh, F, Hodgins, S, Hilliker, C, Freedman, M, Courtman, D.W
Format: Article
Language:English
Subjects:
Advanced Basic Science
Other
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1465-3249
DOI:10.1016/j.jcyt.2018.02.108